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Abstract
HYDROGEN SULFIDE AS AN ALLOSTERIC MODULATOR OF ATP SENSITIVE
POTASSIUM CHANNELS IN COLONIC INFLAMMATION
by Aravind Reddy Gade
A thesis submitted in partial fulfillment of the requirements for the degree of Masters of Science
in Pharmacology at Virginia Commonwealth University.
Virginia Commonwealth University, 2012
Director: Hamid I. Akbarali, Ph.D.
Professor, Department of Pharmacology and Toxicology
The ATP sensitive potassium channel (KATP) in mouse colonic smooth muscle cell is a complex
containing a pore forming subunit (Kir6.1) and a sulfonyl urea receptor subunit (SUR2B). These
channels are responsible for maintaining the cellular excitability of the smooth muscle cell which
in turn regulates the motility patterns in the colon. We used whole-cell voltage-clamp techniques
to study the alterations in these channels in smooth muscle cells in experimental model of colitis
(colonic inflammation). Colitis was induced in BALB/C mice following an intracolonic
administration of trinitrobenzene sulfonic acid (TNBS). KATP currents were measured at Vh -60
mV in high K+ external solution. The dose-response to levcromakalim (LEVC), a KATP channel
opener, was significantly shifted to the left in the inflamed smooth muscle cells. Both the affinity
and maximal currents induced by LEV were enhanced in inflammation. The EC50 in control was
6259 nM (n=10) and 422 nM (n=8) in inflamed colon while the maximal currents were 9.9 ±
0.71 pA/pF (60 μM) in control and 39.7 ± 8.8 pA/pF (3 μM) following inflammation. Similar to
LEVC, KATP currents activated by sodium hydrogen sulfide (NaHS) (10-1000 μM) were
significantly greater in inflamed compared to controls. In control cells, pretreatment with 100
x

µM NaHS shifted the EC50 for LEV-induced currents from 2838 nM (n=6) to 154 nM (n=8).
These data suggest that NaHS can act as an allosteric modulator for LEV-induced KATP currents.
Decreased colonic motility may result from enhanced KATP activation by increased release of
H2S in colitis.

xi

CHAPTER 1 INTRODUCTION
Ulcerative colitis is a form of inflammatory bowel disease that usually occurs in the
colon. The main symptom seen in this disease is altered motility patterns in the colon, leading to
a bloody diarrhea or constipation. These alterations are assumed to be mediated through the
decreased contractile force generated by the smooth muscle cell

21, 22, 23, 24

. Contractility of the

smooth muscle cell is primarily dependent on K+ and Ca+2 channels present on its membrane.
Hence any alteration in the ion channel activity of colonic smooth muscle cell might alter the
motility patterns in colon.
Several earlier reports suggested a decrease in the activity of voltage gated Ca+2 channels (Ltype) of colonic smooth muscle cell in inflammation due to decreased expression or modification
of the channel2, 3, 4. Apart from these reports, previous findings from our lab have shown an
enhanced activity of ATP sensitive potassium channels (KATP) of the colonic smooth muscle cell
in an experimental model of colitis (DSS)1. The underlying mechanism of this alteration was not
clearly understood. As the name suggest, the activity of this channel is modulated by the
intracellular concentration of ATP. Apart from this, recent reports also suggest the modulation of
channel activity by different endogenous signaling molecules like H2S 17, 18, 19. Recent reports
also suggest an increased activity of enzymes synthesizing H2S in ulcerative colitis15. This
showed a possible involvement of endogenous H2S in the enhanced activity of KATP channels in
ulcerative colitis.
In the present study, we used electrophysiological techniques (Patch Clamp) to examine the
alterations seen in the KATP channel currents in TNBS model of colonic inflammation
1

(experimental model of colitis) through a dose-response study and demonstrate that, the affinity
and efficacy of KATP channel opener, Levc induced currents were enhanced in inflammation. We
examined the effect of exogenous H2S on KATP channel in a similar setup and demonstrate that,
H2S activated the channel at high concentrations and at low concentrations increased the
sensitivity of the channel to the opener Levc. We conclude that this modulation of KATP channel
activity by H2S might be a possible mechanism for the channel alteration in colonic
inflammation.
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CHAPTER 2 BACKGORUND

2.1 Ulcerative Colitis:
Ulcerative Colitis is a form of inflammatory bowel disease (IBD) seen in the colon. It is a
disorder of modern society and its frequency has been increasing in developed countries since
the mid-20th century. This relapsing and remitting disease is characterized with tissue
inflammation and degradation. Inflammation is primarily restricted to the mucosal region of the
wall of colon but in severe cases might go deep into the tissue. There is no known cause for this
disease, but there is a presumed involvement of genetic component in its incidence. Evidence
suggests that, defects in the immune system might lead to the incidence of the disease35, 36. At
any point of time, 50% of the patients are asymptomatic while 30% of them have mild symptoms
and 20% of them have severe symptoms. Primary symptom seen in this disease is the altered
motility patterns in colon leading to either a bloody diarrhea or constipation21-24. A few extra
intestinal symptoms are also seen in rare conditions.
This disease is quite similar to Crohns disease in symptoms but differs in several other aspects.
While ulcerative colitis is restricted to colon and rectum, Crohns may spread to any part of the
GIT. The etiology and pathophysiology involved in the incidence of these diseases are different
from each other. The treatment involved might be similar in both the cases, as they both involve
defects in immune system35, 36.
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2.2 ATP sensitive potassium channels (KATP):
As the name suggests, these channels are sensitive to intracellular ATP and link the
electrical activity of cell membrane to the cellular metabolism. KATP channels are hetero
octomers comprised of two subunits, the sulfonylurea receptor subunit (SUR1 or SUR2A or
SUR2B) and the inward rectifying pore forming K+ channel subunit (Kir 6.1 or Kir6.2).
Association of these two subunits forms a functional channel on the cell membrane. Sulfonylurea
receptor subunit provides the binding site for channel opener and blocker on the extracellular
side, whereas the K+ channel subunit provides the binding site for ATP on the intracellular side34,
38

. Association of these subtypes of subunits is different in different parts of the body. This

association of the sub-types of subunits determines the function of channel in the body. This
combination of subunits also determines the sensitivity towards channel agonists and
antagonists34, 12.
KATP channels are known to play an important role in maintaining the contractility of the
vascular smooth muscle cell through which it maintains the vascular tone and thus the blood
pressure6-9.
KATP channels play a particularly important role in the pancreatic β cells, where it links the
change in blood glucose to insulin secretion and modulates the uptake of glucose10-12. This
functional role led to the discovery of drugs targeting KATP channels (sulfonylureas) for the
treatment of diseases like type-2 diabetes13, 14.
KATP channel in the colonic smooth muscle cell is a complex containing a pore forming K+
channel subunit (Kir6.1) and a sulfonyl urea receptor subunit (SUR2B)1. These channels are
inwardly rectifying. At resting membrane potential these channels regulate the contractility of
4

the smooth muscle cell. The activity of channel is thus crucial in maintaining the motility
patterns of the colon5. The activity of this channel was found to be enhanced in an experimental
model of colitis. This enhanced activity is assumed to responsible for the reduced contractile
force of the muscle in colonic inflmattaion1.

Diagramatic representation of the structure of ATP sensitive potassium channels. KATP
channels in colonic smooth muscle cell are hetrooctomers formed by the association two
subunits (SUR2B and Kir6.1). The central Kir6.1 subunit forms the channel pore through which
the potassium ions move, whereas the SUR2B subunits are regulatory and associated to each
Kir6.1 subunit34.

5

2.3 Hydrogen Sulfide (H2S):
Hydrogen sulfide is a colorless toxic gas well known for its harmful effects. Research
done in the past few years established that H2S is synthesized in different parts of the mammalian
body. H2S is synthesized from the amino acid L-Cysteine by the enzymes Cystathionine β
synthase (CBS) and Cystathionine γ lyase (CSE) 16, 17. Apart from these enzymes it is also known
to be produced by the gut bacteria. H2S has been placed along with NO and CO in the list of
gasotransmitters16, 46. Gasotransmitters are endogenously produced gaseous molecules known for
their involvement in modulating physiological functions through different signaling processes.
H2S signals by targeting the thiol groups of free cysteines residues on the target protein (ssulfhydration)17. Unlike nitrosylation of cysteine residues by NO, sulfhydration by H2S is a
stimulating signal most of the time16. There are many targets in the mammalian body, which
were shown to be sulfhydrated by exogenous H2S. Some of the important targets include ion
channels like KATP channels and enzymes like GAPDH whose activity was increased upon
sulfhydration with H2S17, 18, 20, 48. Endogenously produced H2S was shown to be involved in the
modulation of different physiological functions. Recent reports suggest H2S as an endothelium
derived hyperpolarizing factor responsible for the vasodilatation of blood vessels through its
action on KATP channels of vascular smooth muscle cell18. It is also shown to act on different
enzymes like GAPDH in liver and increase their activity16.
H2S is also assumed to play an important role in several diseases, primarily inflammation. Recent
reports from Wallace et al.15 demonstrated an increased activity of the enzymes CBS and CSE in
colonic inflammation. There were also other reports suggesting an increase in the sulphate
reducing bacteria in patients with colonic inflammation37. These bacteria are known to produce
H2S in the gut. These findings clearly showed a possibility of increased H2S levels in
6

inflammation. However, it is still argued if the role played by H2S is pro-inflammatory or antiinflammatory.
The goal of this study is to identify if the increased H2S concentration is modulating the
enhanced activity of KATP channel in colonic inflammation. To test this hypothesis we studied
the correlation between the actions of H2S on KATP channels with the enhanced channel activity
seen in colonic inflammation.

7

CHAPTER 3 MATERIALS AND METHODS
3.1 Materials:
TNBS (Tri-Nitro Benzene Sulfonic acid), Glib and Trypsin (from Bovine Pancrease) were
purchased from Sigma. Levc was purchased from Tocris bioscience. Hydrogen sulfide was
purchased from Cayman chemicals. Collagenase was purchased from Worthington (Lakewood,
NJ). Serum Bovine Albumin was purchased from American Bio-Analytical. Sodium chloride
(NaCl), magnesium chloride (MgCl2), calcium chloride (CaCl2), glucose, ATP disodium salt,
HEPES, EGTA and tetraethylammonium chloride (TEA) were purchased from Sigma. MPO
activity assay kit was purchased from Invitrogen.
3.2 Animals:
Adult male BALB/C mice that weighed 25-30g were housed in animal care quarters under a
12:12 hr light-dark cycle with food and water. All the experiments were done according to
protocols approved by the Virginia Commonwealth University IACUC.
3.3 Methods:
3.3.1 Induction of Inflammation:
Inflammation was induced in the colon of the BALB/C mice through intracolonic administration
of TNBS (0.1 ml). Weights of the mice were monitored on a daily basis and MPO assay was
performed on the colon tissue at different time points after the administration of TNBS to
determine the severity of inflammation. TNBS solution was prepared by diluting the stock with
50% ethyl alcohol in 1:1 ratio. Vehicle controls were prepared by diluting 1X PBS solution with
50% ethyl alcohol in 1:1 ratio.
8

3.3.2 MPO Assay:
Colon samples were collected from control and inflamed mice. Cell lysate was prepared from
these samples and centrifuged. Supernatant collected from centrifuged sample was used for the
assay. Chlorination activity assay was performed to determine the MPO activity of the sample.
Assay was performed as directed by the protocol provided along with the MPO assay kit.
3.3.3 Cell-isolation:
Smooth muscle cells were isolated from the colon of male BALB/C mice (25-30gms) as
described previously1. Mice were euthanized and the colon was isolated. The colon was then cut
open across the myenteric border and the mucosa is scrapped off to isolate the muscle layer. This
whole process was carried out in a low calcium tyrode solution. The muscle layer was then cut
into small pieces and transferred into tyrode solution containing 1.5 mg collagenase, 1mg trypsin
and 5mg serum bovine albumin in 5ml for 10-12 minutes at 37oC. Then the tissue was subjected
to gradual trituration with a flame polished glass bore. The partially digested tissue was then
transferred into the enzyme free solution and subjected to further trituration and monitored under
microscope to check for the dispersed cells. The dispersed cells were stored on ice and used
within 6 hrs. All the electrophysiological recordings were done at room temperature (22-25oC).
3.3.4 Electrical Recordings:
Standard whole-cell configuration was used for all recordings. The Patch-clamp amplifier used
was HEKA EPC 10. The micropipettes were prepared on a Flaming-Brown horizontal puller (P87; Sutter Instruments) and fire polished. Resistance of the pipettes used was 5-10MΩ. The
currents were recorded in a gap-free protocol and an I-V protocol. In gap-free protocol, the cell
was held at a voltage of -60mV and currents were measured continuously for a period of 15 mins

9

where as in I-V protocol, the cell was held at a voltage of -60mV and the currents were measured
from the -120mV to 0 mV in series of pulses.
3.3.5 Solutions:
Different solutions were used for recordings in the whole-cell configuration. The solutions used
are listed in the table 1. The low calcium tyrode solution was equilibrated with 95%O2 – 5%CO2.
pH of all bathing solutions was adjusted to 7.4 using 3N KOH. The KATP currents were recorded
in a High K+ (140 K+ External) external bath solution which specifically isolated and amplified
the KATP currents by blocking other possible potassium channels.
Table 1. Solutions used for cell isolation and electrophysiological recordings (values are in
millimolar).

Whole Cell
Recording
Low Ca+2
Tyrode
137 NaCl
2.7 KCl
0.008 CaCl2
0.88 MgCl2
0.36 NaH2PO4
12 NaHCO3
5.5 Glucose

Internal
100 K+
asparate
30 KCl
5 HEPES
1 MgCl2
10 EGTA
0.1 ATP

5 K+ External

140 K+ External

135 NaCl
5.4 KCl
0.33 NaH2PO4
5 HEPES
1 MgCl2
2 CaCl2
5.5 Glucose

140 KCl
10 HEPES
1 MgCl2
0.1 CaCl2
1 TEA

3.3.6 Data-Analysis:
Sigma-Plot 11.0 was used for the analysis of the data and to plot the graphs. EC50 values were
calculated using 4 parameter logistic nonlinear regression model in sigma plot. Significance
levels were determined using unpaired t-tests. P≤0.05 was considered significant.
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CHAPTER 4 RESULTS
Mice treated with TNBS displayed a significant loss in weight on day 1 and 2 after the
treatment. MPO assay performed with the colon tissues also displayed a significant increase in
the MPO activity on day 1 and 2 after treatment with TNBS. This increase in the MPO activity
also showed significant differences when compared with mice treated with control vehicle (Fig
1).
4.1 Enhancement of the KATP Channel opener induced currents in inflammation:
In order to study the alterations in KATP channel activity in inflammation, currents were recorded
from freshly dispersed smooth muscle cells of distal colon using the whole cell configuration of
the voltage clamp technique. To identify the KATP channel currents, cells were bathed in a high
K+ (140 mM) external bath solution, held at Vh -60 mV and dialyzed with low ATP (0.1 mM) in
the pipette solution as previously described1. Perfusion from a low (5.4 mM) to high K+ solution
resulted in inward currents. The basal currents recorded in the high K+ solution were 0.9±0.12
pA/pF (n=14) in controls, and 5.5 ±1.4 pA/pF (n=10) in colonic smooth muscle cells from TNBS
treated mice (day 2 after treatment with TNBS), henceforth referred to as inflamed cells (Fig
3A). The high K+-induced currents were abolished by Glib suggestive of increased basal activity
of KATP in inflamed cells. The average capacitance was 58.93±2.05 pF (n =39) in control and
45.40±2.28 pF (n=20) in inflamed cells. The KATP channel opener, Levc, further enhanced
inward currents at -60 mV. The channel opener- induced currents measured after subtraction of
baseline currents in high K+ showed a remarkable increase from 9.9±0.71 pA/pF (n=12) in

11

control cells to 39.7 ± 8.8 pA/pF (n=10)

in cells from inflamed colon demonstrating an

enhancement of almost 7 fold in inflammation (Fig: 3B).
Test depolarizations from -120 mV to 0mV in 10 mV increments (Vh -60 mV) resulted in timeindependent and weakly voltage dependent currents.

Fig 4 and 5 shows current-voltage

relationships for Levc-induced currents in control and inflamed cells in the presence of various
concentrations of Levc. Compared to control cells, inflamed cells induced significantly larger
currents at each potential and were more sensitive to the channel opener. A dose-response curve
for Levc-induced currents was plotted at each voltage. Fig 6 shows the dose-response at -60 mV
for control (open circles) and inflamed (closed circles). There was both a leftward shift in the
dose-response and an enhancement of the maximal current in inflamed cells. The significant
shift in potency was evident when current amplitudes at each concentration were plotted as a
fraction of the maxima (Fig 6B). The EC50 values calculated for Levc shifted from 6259 nM
(95% C.L: 4909 – 7625 nM) (n=10) in control cells to 422 nM (95% C.L: 273 – 522 nM) (n=8)
in cells from the inflamed colon showing a tenfold difference. This suggested that inflammation
results in both an increase in affinity and efficacy for the KATP channel opener. To further
examine whether there was a voltage-dependency to the affinity for Levc, Dose-response curves
were plotted and the EC50 values were plotted for each potential (Fig 7A). The EC50 values were
not different at any of the different potentials with inflamed cells being more sensitive to Levc
(Fig 7B).

12

Figure 1: Disease activity index. A: % decrease in the weight of animals after treatment with
TNBS (n=13) and Saline (n=5). B: MPO activity in mice in control and after treatment with
TNBS (n=4) and Saline (n=5). ***P<0.001, **P<0.01
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Figure 2: Levc induced currents in control and inflamed cells. A. Raw traces showing the
inward current induced by the channel opener levc in a whole-cell recording of gap-free protocol
at -60mV in the control and inflamed cells.
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Figure 3: Amplitude of KATP currents in control and inflamed cells A: Normalized amplitude of
basal KATP currents in control and inflamed cells. (con: 0.9±0.12 pA/pF, Inf: 5.5±1.4 pA/pF) B:
normalized amplitude of levc (10µM) induced currents in control and inflamed cells. (con:
9.9±0.71 pA/pF, Inf: 39.6±8.8 pA/pF)

15

Figure 4: Voltage and dose dependence of levc induced currents. Currents were recorded in a
series of step voltages applied from -120 to 0mV in 10mV increments from a holding potential of
-60mV in high K+ solution. A,B: current traces in high K+ and in different concentrations of
levc in control and inflamed cells. Note the difference in scale bars.
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Figure 5: Currents-voltage relationship. Current-voltage
concentrations of levc in control and inflamed cells.

17

relationship

with

different

Figure 6: Dose-response relation of levc. A: The normalized amplitude of current induced at
each dose of levc measured at a holding voltage of -60mv in the smooth muscle cells from
control and inflamed colon. B: The % of current induced at each dose of levc as a function of the
maximum current induced at a holding voltage of -60mv in the smooth muscle cells of the
control and inflamed colon. Con (n=10) Inf (n=8).
18

Figure 7: Voltage dependence of calculated EC50. A: The normalized amplitude of current
induced at each dose of levc measured at voltages ranging from 0mV to -120mV (Blue lines –
Control, Red lines – Inflamed). B: Voltage dependence of calculated EC50 values in control and
inflamed cells.
19

4.2 Effect of KATP channel blocker in inflammation:
We next tested whether the KATP channel blocker, Glib demonstrated any difference in the
potency towards inhibition of Levc-induced currents during inflammation. A cumulative doseresponse for glibemclamide induced inhibition of the KATP currents were conducted in the
presence of 10 uM Levc. (Fig: 8). While there were significantly larger Levc-induced currents
in inflamed cells, the dose-response relationship showed no difference in the potency of Glib to
inhibit KATP currents in control or inflamed cells. The IC50 values were 183 nM(95% C.L: 154 –
217nM) (n=6) in control and144 nM(95% C.L: 128 – 162nM) (n=5) in the cells from inflamed
colon (Fig 9).

20

Figure 8: Effect of Glib on KATP channels in inflammation. Raw traces showing the inhibition of
the levc induced currents by different concentrations of glib in a whole-cell recording through
the gap-free protocol at -60mV in control and inflamed cells.
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Figure 9: Dose-Response of Glib in control and inflamed cells. Dose-response curve plotted
with the % of current inhibited at different concentrations of glib as a function of maximum
current inhibited. Con (n=6) and Inf (n=5).
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4.3 Effect of hydrogen sulfide on KATP channels of colonic smooth muscle cell:
We next examined the effect of hydrogen sulfide, an endogenous signaling molecule whose
levels have been shown to be increased in colonic inflammation15. Exogenous sodium hydrogen
sulfide (NaHS) (1 mM) when added to the external bath solution induced inward currents at 60mV in a gap-free protocol. The currents were abolished by Glib (10 uM). Similar to the effects
of Levc, the inward currents activated by 1M NaHS were significantly larger in inflamed cells
8.6±1.4 pA/pF (n=6) than control 2.47±0.1 pA/pF (n=7)
We also tested the dose-dependence of NaHS in control and inflamed cells in a similar setup.
There was a significant shift in the dose-response curve to the left in inflamed cells with an
increase in the maximal currents. When plotted as the fraction of maximal currents, the EC50
values shifted from 461 µM (95% C.L: 376 – 564µM) (n=6) in control cells to 199 µM (95%
C.L: 140 - 283µM) (n=6) in inflamed cells (Fig: 11B).
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Figure 10: Effect of H2S on KATP channels of colonic smooth muscle cell. Raw traces showing
the NaHS (H2S donor) induced currents in a whole cell recording at -60mV voltage through a
gap-free protocol in control and inflamed cells.
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Figure 11: Amplitude of H2S induced currents in control and inflamed cells A: Normalized
amplitude of inward currents induced by NaHS in control and inflamed cells. (Con: 2.47±0.5
pA/pF (n=6), Inf: 10.72±1.9 pA/pF (n=7)) B. The % of current induced at each dose of NaHS as
a function of the maximum current induced at a holding voltage of -60mv in the smooth muscle
cells of the control and inflamed colon. **P<0.01
25

4.4 Effect of H2S on KATP opener induced currents:
In order to examine if NaHS acts as an alloesteric modulator of Levc-induced KATP currents, a
low dose of the hydrogen sulfide (100µM) was bath applied prior to conducting Levc doseresponse. In presence of 100 uM, the currents activated were 0.47±0.04 pA/pF. In the presence
of this concentration of the H2S the channel opener showed an increased affinity and induced
currents at lower doses. The curve plotted shifted to the left and the EC50 values calculated
shifted from 2838nM (95% C.L: 954 – 4625 nM) (n=6), In 100µM NaHS:154.9nM (95%C.L: 94
– 251nM) (n=8) in the presence of 100µM NaHS (Fig 13) , demonstrating an increase in affinity
of the drug similar to what was seen in the case of inflammation. At this concentration of NaHS,
there was no increase in the maximal amplitude of current induced by Levcomakalim (Fig 13A).
This study was repeated in the presence of a higher concentration of NaHS (1mM) where a
maximal concentration of the channel opener (10µM) was used to induce KATP currents. The
inward currents induced by the opener showed an increase from 10.5±1.6 pA/pF (n=6) in the
presence of 100µM H2S to 22±5.4 pA/pF (n=5) in the presence of 1mM of H2S demonstrating an
increase in the efficacy of the drug in the presence of higher concentration of hydrogen sulfide
(Fig 14, 15).
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Figure 12: Effect of H2S on levc induced currents. Current traces in the presence of different
concentrations of levc in control and in the presence of 100µM NaHS.
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Figure 13: Levc Dose-Response in the presence of H2S A: The amplitude of current induced at
each dose of levcromakalim measured at a holding voltage of -60mv in the smooth muscle cell
under control conditions (n=6) and in the presence of 100µM NaHS (n=8). B: The % of current
induced at each dose of levcromakalim as a function of the maximum current induced at a
holding voltage of -60mv in the smooth muscle cell under control conditions and in the presence
of 100µM NaHS.
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Figure 14: Response of Levc in 1mM NaHS. Current traces showing the response to Levc in
control and in the presence of 1mM NaHS.
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Figure 15: Levc induced currents in different concentrations of NaHS Amplitude of current
induced by 10µM levc in the control cells and in the presence of different doses of NaHS (H2S
donor). Amplitude of Lev-induced currents is enhanced in the presence of high NaHS
demonstrating an increase in efficacy of levc. (Con: 9.9±0.71 pA/pF(n=6), Con+100µM NaHS:
10.5±1.6 pA/pF(n=8), Con+1mM NaHS: 22±5.4 pA/pF(n=5)).
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4.5 Effect of NEM on opener and H2S induced current:
In order to examine the involvement of cysteine residues in the action of H2S, the effect of NEM
(an alkylating agent of free cysteine residues) was tested on NaHS and Levc induced currents. In
the presence of 2mM NEM, the responses produced by NaHS and Levc showed a huge decrease
indicating a strong involvement of cysteine residues on their action (Fig 16) (NaHS induced
currents reduced from 2.47±0.56 pA/pF in control to .0397±0.001 (n=4) in the presence of NEM.
Levc induced currents reduced from 9.9±0.71 in control to 0.45±0.3 in the presence of NEM
(n=4)) (Fig 17).
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Figure 16: Effect of NEM on Levc and H2S induced currents. Current traces showing the
response to Levc and NaHS in control and in the presence of 2mM NEM.
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Figure 17: Amplitude of current inhibited by NEM. Bar-Graph showing the quantified
differences in the amplitude of drug induced currents blocked by NEM. *** P<0.001
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CHAPTER 5 DISCUSSION
H2S was previously shown to play an important role in inflammation15,
known to act on KATP channels

17, 18, 20

19

and is also

. Therefore, we examined the correlation between the

effect of H2S and the enhanced activity seen in KATP channel of colonic smooth muscle cell in
inflammation.
Ulcerative colitis is a form of inflammatory bowel disease (IBD) that usually occurs in the colon.
There are frequent alterations seen in the motility patterns of colon in people with this disease 21,
22, 23, 24

. Previous studies have demonstrated changes in the ion channel activity of colonic

smooth muscle cell which might be mediating these altered motility patterns. Previously, Jin et
al.1 demonstrated an enhanced Levc induced whole cell and single channel activity of KATP
channel in the colonic smooth muscle cell of DSS treated mice. To further examine this role of
KATP channels in inflammation, we conducted a dose response study with the channel opener,
Levc on the colonic smooth muscle cell of TNBS treated mice. Through this study we
demonstrated an increase in basal activity (Fig: 3A) of the KATP channel along with a change in
efficacy and potency of the channel opener Levc in colonic inflammation (Fig: 6). This study
displayed that, colonic inflammation is associated with increased sensitivity of KATP channels of
colonic smooth muscle cell towards the channel opener Levc. In a similar setup, a dose-response
study was conducted with a KATP channel blocker Glib, whose effect didn’t show any significant
enhancement in potency in the colonic smooth muscle cell of TNBS treated mice (Fig: 9). This
suggests that, the colonic inflammation has induced an increase in sensitivity of KATP channel
towards the channel opener but not the channel blocker.
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H2S is a gaseous signaling molecule produced in different parts of the body. Previous reports
from Wallace et al.15 demonstrated an increased capacity of the colonic tissue (Increased activity
of enzymes CBS and CSE) to synthesize H2S in TNBS treated rats. These enzymes are known to
be expressed in the smooth muscle cells, mucosal and myenteric neurons etc of the colon15, 39.
Wallace study demonstrates a possibility of increased H2S concentrations in colon in
inflammation which can expose the KATP channels to more amount of H2S. Wallace also showed
that, upon inhibiting the synthesis of H2S or blocking the KATP channel increased the mortality
rate in animals with colonic inflammation. This demonstrates that, H2S and KATP might play a
protective role in colonic inflammation. KATP channel is a well established target of H2S, which
was previously shown to activate the KATP channels in the different parts of the body
29

20, 25, 26, 27,

. In our study we demonstrated that, H2S induced activity of KATP channel in colonic smooth

muscle cell is similar to that of a channel opener, Levc. Dose-response study conducted with H2S
on smooth muscle cell from control and inflamed colon tissues also displayed a similar behavior
as seen with Levc (Fig 11).
Apart from that, our drug combination studies with H2S and Levc demonstrated an increase in
potency of Levc in the presence of exogenous H2S (Fig: 6)… This increase in the potency was
observed in the presence of lower concentrations of H2S (Fig 13). In the presence of higher
concentrations of H2S, there was also an increase in the efficacy of the channel opener (Fig 15)...
This behavior of Levc was similar to what was seen in the case of colonic inflammation. Our
study along with Wallace previous reports, demonstrate a possibility of H2S mediated
enhancement of KATP channel activity in colonic inflammation.
H2S usually targets the thiol groups of free cysteine residues on the target protein and forms a
persulfide (s-sulfhydration). It was well established in the literature by Snyder’s group and others
35

that, H2S signals through the s-sulfhydration of the free cysteine residues on the target protein16,
17, 28
29

. This signaling mechanism was assumed to modulate different physiological functions 16, 17,

. The mechanism involved or target sites involved in the H2S mediated effects on the KATP

channels are not well understood. Mustafa et al.18 recently demonstaretd that, Kir 6.1 subunit of
the KATP channel was sulfhydrated upon exposure to H2S through a biotin switch assay. Work
done by Minho Kang in our lab used a similar approach to study the sulfhydration of the KATP
channel in colonic smooth muscle after exposure to the H2S. We found that SUR2B subunit of
the KATP channel gets sulfhydrated upon exposure to H2S. This sulfhydrated subunit might be
mediating the H2S induced allosterism of the KATP channel.
H2S induced effect can be reversed by reducing agents like DTT, which specifically break the
disulfide bonds between the cysteine residues or can be inhibited upon pre-treatment with NEM,
which alkylate the free cysteine residues and prevent s-sulfhydration. S-Sulfhydration of the
SUR2B seen through the biotin switch assays was reversed upon treatment with DTT and was
inhibited upon pretreatment with NEM (Kang et al. unpublished data). In contrast to the earlier
results, H2S induced activity of the channel was not reversed after exposure to DTT (data not
shown) but was completely inhibited upon pretreatment with NEM, an alkylating agent of free
cysteine residues (Fig 16, 17). Not only H2S induced currents but also Levc induced currents
were inhibited upon pretreatment with NEM. Thus the functional data along with the
biochemical data demonstrated that, sulfhydration of cysteine residues of SUR2B is responsible
for the activation produced by H2S.
There is increasing evidence showing the contributions of H2S as a modulator of inflammation15,
40, 41, 47

. Although there were several earlier reports suggesting its contribution to the

pathogenesis of ulcerative colitis and colon cancer42-45, there are also equal numbers of reports
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suggesting its protective role. Moreover, Wallace previous study has shown the protective role of
both H2S and KATP channel in colonic inflammation and results from the present study
demonstrate the allosteric modulation of KATP channel by H2S but it is still to be determined if
the protective role of H2S is mediated through the KATP channels.
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CHAPTER 6 CONCLUSIONS AND FUTURE WORK
6.1 Conclusion:
In summary, the present study provides electrophysiological evidence showing an
enhanced sensitivity of the KATP channel towards channel opener in colonic inflammation and in
the presence of H2S. This correlation in the activity of KATP channel in inflammation and in the
presence of H2S, along with previous reports display a possible role of H2S mediated
enhancement of KATP channel activity in colonic inflammation. This study along with other
biochemical evidence (Kang et al., unpublished data) in our lab demonstrated a possible
mechanism involved in the action of H2S, which might be by an allosteric modulation through
the s-sulfhydration of SUR2B subunit of the channel.
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6.2 Future Work:
The work done so far has shown the alterations seen in KATP channels in colonic
inflammation and its allosteric modulation by H2S. Future studies can be done to identify the
cysteine residues involved in the s-sulfhydration of the channel by H2S using a site directed
mutagenesis. Behavioral studies can be done to identify on the role played by KATP channels and
H2S in colonic inflammation.
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